Ifebemtinib plus garsorasib in previously treated metastatic colorectal cancer with KRAS^G12C mutation: a multicentre, randomised, phase 1b/2 trial.

DOI:10.1016/S1470-2045(26)00175-0
作者：Zhengbo Song,?Liming Zhu,?Ying Liu,?Rongbo Lin,?Xingya Li,?Yongzhong Luo,?Yuan Yuan,?Huaqiu Shi,?Yiping Zhang,?Baoyuan Zhang,?Yinxin Zhu,?Zaiqi Wang,?Xiangdong Cheng
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/S1470-2045(26)00175-0